Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02789176 · ClinicalTrials.gov registry record
Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
A clinical trial of Neonatal Seizures, sponsored by University of Michigan.
- Completed
- Registry status
- 303
- Enrollment target
- 11
- Study locations
NCT02789176 is a study of Neonatal Seizures that has completed, run by University of Michigan. The registered enrollment target is 303 participants. The trial reports 11 study locations across 7 states.
The verdict
NCT02789176, a study of Neonatal Seizures, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 303 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this study is to examine whether the duration of treatment with phenobarbital has an impact on neurodevelopmental and epilepsy outcomes, as well as parent and family well-being, after neonatal seizures.
Conditions Studied
Interventions
- OTHER Surveys
- OTHER EEG
Study Locations (11)
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children's Hospital - Boston
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
California
- University of California, San Francisco - San Francisco
- Stanford University - Stanford
District of Columbia
- Children's National Medical Center - Washington D.C.
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Duke University - Durham
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2016-10 |
| Est. Completion | 2020-03-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02789176
The ClinicalTrials.gov registry entry for NCT02789176 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Seizures appearing as the primary indexed condition, and to 2 interventions - of which Surveys is the first listed.
NCT02789176 reports 11 study locations spanning 7 distinct geographic areas - top geographies include Massachusetts, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02789176 about?
NCT02789176 is a clinical study titled "Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study". The purpose of this study is to examine whether the duration of treatment with phenobarbital has an impact on neurodevelopmental and epilepsy outcomes, as well as parent and family well-being, after neonatal seizures.
What is the current status of trial NCT02789176?
This trial is currently completed. The enrollment target is 303 participants. The study started on 2016-10. Estimated completion is 2020-03-24.
What conditions does trial NCT02789176 study?
This clinical trial studies the following conditions: Neonatal Seizures.
What interventions are being tested in trial NCT02789176?
The interventions under investigation include: Surveys (OTHER), EEG (OTHER).
Who is sponsoring clinical trial NCT02789176?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02789176 being conducted?
This trial has 11 study locations across California, District of Columbia, Massachusetts, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.